(Q42116041)

16 October 2017

Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole (English)

1 reference

16 October 2017

1 reference

1 reference

T Andersson

1

1 reference

16 October 2017

J Holmberg

series ordinal

2

1 reference

16 October 2017

K Röhss

series ordinal

3

1 reference

16 October 2017

A Walan

series ordinal

4

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

British Journal of Clinical Pharmacology

16 October 2017

1 reference

16 October 2017

45

1 reference

16 October 2017

369-375

1 reference

16 October 2017

4

1 reference

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

The interaction of proton pump inhibitors with cytochromes P450.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Pharmacokinetics--a relevant factor for the choice of a drug?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Oxidative metabolism of lansoprazole by human liver cytochromes P450.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Drugs other than H2-receptor antagonists as clinically important inhibitors of drug metabolism in vivo

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Characterization of human liver cytochromes P-450 involved in theophylline metabolism

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Specific and dose-dependent enzyme induction by omeprazole in human beings.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873971

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

17 August 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.T01-1-00702.X

Omeprazole treatment does not affect the metabolism of caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.T01-1-00702.X

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.T01-1-00702.X

A urinary metabolite ratio that reflects systemic caffeine clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.T01-1-00702.X

Variability in caffeine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.T01-1-00702.X

Determination of omeprazole and metabolites in plasma and urine by liquid chromatography

21 January 2018

1 reference

12 December 2020

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

12 December 2020

Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies

1 reference

12 December 2020

Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation

1 reference

12 December 2020

Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers

1 reference

12 December 2020

Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers

1 reference

12 December 2020

Pharmacokinetic interaction between lansoprazole and theophylline

1 reference

12 December 2020

Effects of lansoprazole on pharmacokinetics and metabolism of theophylline

1 reference

12 December 2020

Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions

1 reference

12 December 2020

10.1046/J.1365-2125.1998.T01-1-00702.X

Identifiers

DOI

1 reference

16 October 2017

1 reference

16 October 2017

1 reference